<

PHARNEXT (EPA:ALPHA) Pharnext: Findings From ‘Real-World’ Digital Lifestyle Study, CMT&Me, on Symptom Burden of Charcot-Marie-Tooth Disease Type 1A Published in the Journal of Clinical Neuromuscular Disease

Transparency directive : regulatory news

14/09/2022 08:31



Other stories

17/05/2024 11:14
17/05/2024 11:42
17/05/2024 11:00
17/05/2024 08:01
16/05/2024 22:32
17/05/2024 11:22
17/05/2024 12:22
17/05/2024 06:00
17/05/2024 03:26
17/05/2024 11:12
17/05/2024 05:16
17/05/2024 10:40
16/05/2024 19:22
16/05/2024 09:01
17/05/2024 11:15
17/05/2024 08:33
17/05/2024 10:34
17/05/2024 09:31
16/05/2024 17:10
16/05/2024 23:01
16/05/2024 18:24
16/05/2024 20:27
17/05/2024 06:02
17/05/2024 01:45
17/05/2024 09:04
17/05/2024 11:03
17/05/2024 12:02
17/05/2024 07:50
17/05/2024 11:06
17/05/2024 07:02
17/05/2024 07:36
16/05/2024 11:05
15/05/2024 11:19
15/05/2024 17:00
17/05/2024 11:33
16/05/2024 16:36
17/05/2024 07:10
16/05/2024 10:15